ABL (gene)
Human gene encoding a protein-tyrosine kinase
Overview
The ABL gene encodes a protein known as the Abelson murine leukemia viral oncogene homolog 1, or ABL1. This protein is a member of the tyrosine kinase family and plays a crucial role in various cellular processes, including cell division, adhesion, and stress response. The ABL gene is located on chromosome 9 in humans.
Structure
The ABL1 protein consists of several domains that contribute to its function. These include the SH3 domain, SH2 domain, and a tyrosine kinase domain. The SH3 and SH2 domains are involved in protein-protein interactions, while the tyrosine kinase domain is responsible for its enzymatic activity.
Function
The ABL1 protein is involved in the regulation of the cytoskeleton, which is essential for cell shape and movement. It also plays a role in the DNA damage response and can influence apoptosis, or programmed cell death. ABL1 is activated in response to various cellular signals and can translocate to different cellular compartments, including the nucleus.
Clinical significance
Mutations or translocations involving the ABL gene can lead to the development of certain types of cancer. One of the most well-known translocations is the Philadelphia chromosome, which results from a translocation between chromosomes 9 and 22. This translocation creates the BCR-ABL fusion protein, which is associated with chronic myeloid leukemia (CML).
Inhibitors
Several tyrosine kinase inhibitors (TKIs) have been developed to target the BCR-ABL fusion protein in CML. These include imatinib, dasatinib, and nilotinib. These drugs have significantly improved the prognosis for patients with CML by specifically inhibiting the aberrant kinase activity of the BCR-ABL protein.
Research
Ongoing research is focused on understanding the full range of ABL1's functions in normal and cancerous cells. Studies are also exploring resistance mechanisms to TKIs and developing new therapeutic strategies to overcome these challenges.
Related pages
Gallery
-
Structure of Abl1 bound to nilotinib
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian